
浏览全部资源
扫码关注微信
1.550025贵阳, 贵州医科大学公共卫生学院,环境污染与疾病监控教育部重点实验室
2.400038 重庆, 陆军军医大学(第三军医大学)军事预防医学系火箭军医学教研室,创伤、烧伤与复合伤国家重点实验室
3.646000 四川 泸州,西南医科大学附属医院肿瘤科
[张爱华,E-mail: aihuagzykd@163.com ZHANG Aihua, E-mail: aihuagzykd@163.com
[史春梦,E-mail: shicm@sina.com SHI Chunmeng, E-mail: shicm@sina.com
收稿:2019-09-15,
修回:2019-12-11,
纸质出版:2020-02-28
移动端阅览
黄玉, 王子文, 王会兰, 等. 七甲川花菁类荧光小分子IR-61改善大鼠肺纤维化[J]. 第三军医大学学报, 2020,42(4):350-358.
Yu HUANG, Ziwen WANG, Huilan WANG, et al. Fluorescent small molecule IR-61 improves pulmonary fibrosis induced by intratracheal bleomycin in rats[J]. Journal of Third Military Medical University, 2020, 42(4): 350-358.
黄玉, 王子文, 王会兰, 等. 七甲川花菁类荧光小分子IR-61改善大鼠肺纤维化[J]. 第三军医大学学报, 2020,42(4):350-358. DOI: 10.16016/j.1000-5404.201909108.
Yu HUANG, Ziwen WANG, Huilan WANG, et al. Fluorescent small molecule IR-61 improves pulmonary fibrosis induced by intratracheal bleomycin in rats[J]. Journal of Third Military Medical University, 2020, 42(4): 350-358. DOI: 10.16016/j.1000-5404.201909108.
目的
2
探索七甲川花菁类荧光小分子IR-61在肺纤维化发生过程中的作用以及对肺成纤维细胞转分化、增殖和迁移的影响。
方法
2
采用气管滴注博来霉素(bleomycin
BLM,2.5 mg/kg)建立大鼠肺纤维化模型;腹腔注射PBS或IR-61(2.0 mg/kg,每周2次);BLM处理10 d后,尾静脉注射IR-61(2.0 mg/kg),于24 h后取各器官行近红外荧光成像(near infrared fluorescence imaging,NIR),观察IR-61在各器官的蓄积情况;治疗28 d后,取肺组织制作切片,行HE和Masson染色,显微镜下观察;采用RT-PCR、Western blot测定人肺成纤维细胞(human fetal lung fibroblast
HFL1)与原代大鼠肺成纤维细胞转分化及增殖相关基因Collagen-1、Collagen-3、α-SMA、Fibronectin、FOXM1、CCNB1、CDC25b和AURKB的mRNA及蛋白表达;用细胞划痕实验进行迁移检测。
结果
2
① NIR显示:IR-61可靶向至博来霉素诱导的受损伤肺组织。②形态学观察显示:BLM+IR-61组较博来霉素组形态改善,肺塌陷少,纤维结节少。经组织学鉴定,BLM+IR-61处理组较BLM处理组肺纤维化程度低[(0.103 3±0.0145 3)
vs
(0.460 0±0.0378 6),
P
<
0.05
]
。IR-61预处理HFL1与原代大鼠肺成纤维细胞后,用TGF-β1刺激,Western blot和RT-PCR分析结果显示:TGF-β1+IR-61处理组较TGF-β1处理组转分化特异性基因Collagen-1、Collagen-3、α-SMA、Fibronectin的mRNA及蛋白表达降低(
P
<
0.05),同时,增殖特异性FOXM1、CCNB1、CDC25b和AURKB基因的表达也降低(
P
<
0.05),说明IR-61可以抑制TGF-β1诱导的肺成纤维细胞的转分化与增殖的作用。③细胞划痕实验结果显示:TGF-β1诱导肺成纤维细胞迁移活性增强,IR-61能有效抑制肺成纤维细胞的迁移能力。
结论
2
IR-61通过靶向到受损伤的肺组织并通过抑制肺成纤维细胞的转分化、增殖和迁移来减轻博来霉素诱导的肺纤维化。
Objective
2
To evaluate the effects of IR-61 on the development of pulmonary fibrosis and on the proliferation and migration of lung fibroblasts in rats.
Methods
2
Forty male SD rats (6 to 8 weeks old) were randomized equally into normal control group
IR-61 group
bleomycin group and bleomycin+IR-61 group. In the latter 2 groups
rat models of
pulmonary fibrosis were established by intratracheal infusion of bleomycin (2.5 mg/kg). In the 2 groups with IR-61 treatment
IR-61 was intraperitoneally injected at the dose of 2.0 mg/kg 30 min following intratracheal bleomycin infusion and was then administered twice a week. At 10 d after bleomycin treatment
3 rats from each group were selected for IR-61 injection (2 mg/kg)
via
the tail vein to observe the accumulation of IR-61 in each organ at 24 h using near infrared fluorescence imaging (NIR). After 28 d of treatment
the rats were euthanized and the lung tissue was collected for HE and Masson staining. RT-PCR and Western blotting were performed to detect the changes of the expression of the genes related with lung fibroblast transdifferentiation and proliferation (including Collagen-1
Collagen-3
α-SMA
fibronectin
FOXM1
CCNB1
CDC25b and AURKB) in human lung fibroblasts (HFL1) and primary rat lung fibroblasts in response to IR-61 and transforming growth factor-β1 (TGF-β1) treatments; the migration of the cells was assessed using cell scratch test.
Results
2
NIR imaging showed that IR-61 could target the injured lung tissue induced by bleomycin. Morphological observation showed that compared with bleomycin-treated rats
the rats with IR-61 treatment presented with better structural integrity of the lungs with less obvious lung collapse
fewer fibrotic nodules and a significantly milder of pulmonary fibrosis (0.103 3±0.014 53
vs
0.460 0±0.037 86
P
<
0.05). In HFL1 cells and primary rat lung fibroblasts
IR-61 pretreatment prior to TGF-β1 stimulation resulted in significantly lowered mRNA and protein expression of collagen-1
collagen-3
α-SMA
and fibronectin as well as the proliferation-specific genes FOXM1
CCNB1
CDC25b and AURKB (
P
<
0.05). Cell scratch test showed that TGF-β1 treatment significantly increased the cell migration activity
which was effectively suppressed by IR-61 treatment.
Conclusion
2
IR-61 ameliorates bleomycin-induced pulmonary fibrosis in rats by targeting the injured lung tissue and inhibiting the transdifferentiation
proliferation and migration of lung fibroblasts.
FANER R, ROJAS M, MACNEE W, et al . Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis[J ] .Am J Respir Crit Care Med, 2012, 186(4): 306-313. DOI:10.1164/rccm.201202-0282PP.
ROCKEY D C, BELL P D, HILL J A. Fibrosis: A common pathway to organ injury andfailure[J]. N Engl J Med, 2015, 372(12): 1138-1149. DOI:10.1056/nejmra1300575.
Selman M, Pardo A.Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model[J]. Am J Respir Crit Care Med, 2014, 189(10): 1161-1172. DOI: 10.1164/rccm.201312-2221PP.
WANG X, CHEN Z L, LUO S L, et al . Development of therapeutic small-moleculefluorophore for cell transplantation[J ] . Adv Funct Mater, 2016, 26(46): 8397-8407. DOI: 10.1002/adfm.201600996.
WILLIS B C, BOROK Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lungdisease[J]. Am J Physiol Lung Cell Mol Physiol, 2007, 293(3): L525-L534. DOI: 10.1152/ajplung.00163.2007.
AL-TAMARI H M, DABRAL S, SCHMALL A, et al . FoxO3 an important player infibrogenesis and therapeutic target for idiopathic pulmonary fibrosis[J ] . EMBO Mol Med, 2018, 10(2): 276-293. DOI: 10.15252/emmm.201606261.
THIERY J P, SLEEMAN J P. Complex networks orchestrate epithelial-mesenchymal transitions[J]. Nat Rev Mol Cell Biol, 2006, 7(2): 131-142. DOI: 10.1038/nrm1835.
BLACK M, MILEWSKI D, LE T E, et al . FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch inmyofibroblasts[J ] . Cell Rep, 2018, 23(2): 442-458. DOI: 10.1016/j.celrep.2018.03.067.
WYNN T A, RAMALINGAM T R. Mechanisms of fibrosis: therapeutic translation for fibroticdisease[J]. Nat Med, 2012, 18(7): 1028-1040. DOI: 10.1038/nm.2807.
HUANG Y H, ZHOU J, LUO S L, et al . Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial proteintranslocase TIM44[J ] . Gut, 2018, 67(2): 307-319. DOI: 10.1136/gutjnl-2016-311909.
WANG Y, LIAO X Y, SUN J G, et al . Characterization of HIF-1α/glycolysis hyperactive cell population via small-molecule-based imaging of mitochondrialtransporteractivity[J ] . Adv Sci (Weinh), 2018, 5(3): 1700392. DOI: 10.1002/advs.201700392.
WANG Y, LUO S L, ZHANG C, et al . An NIR-fluorophore-based therapeutic endoplasmic reticulum stress inducer[J ] . Adv Mater, 2018, 1:e1800475. DOI: 10.1002/adma.201800475.
JOHNSON N A, SACHINWALLA T, WALTON D W, et al . Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weightloss[J ] . Hepatology, 2009, 50(4): 1105-1112. DOI:10.1002/hep.23129.
曾仁凤, 何振华, 张秀峰.上皮细胞间质转化与肺纤维化的研究进展[J].当代医学, 2014, 20(2): 12-13. DOI: 10.3969/j.issn.1009-4393.2014.2.007.
ZENG R F, HE Z H, ZHANG X F, et al .Research progress of interstitial transformation of epithelial cells and pulmonary fibrosis[J ] . Contemp Med, 2014, 20(2): 12-13. DOI: 10.3969/j.issn.1009-4393.2014.2.007.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621